Home › Funds › Propel Bio Management, LLC › DCTH

Propel Bio Management, LLC position in DCTH

DELCATH SYS INC · Health Care

Propel Bio Management, LLC reported holding 604,664 shares of DCTH (DELCATH SYS INC) in its Q3 2026 13F filing — a position valued at US$9.7M, representing 5.12% of its reported portfolio and ranking #3 among its reported holdings. Propel Bio Management, LLC has disclosed DCTH holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)604.66K sh
Reported value held$9.66M
Portfolio Weight5.12%
First reportedQ4 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Propel Bio Management, LLC's DCTH position evolved

Propel Bio Management, LLC first disclosed a stake in DCTH in Q4 2024 at 17,000 shares (US$205K). The position peaked in Q2 2026 at 871,460 shares, worth US$11.0M. Across 8 filings, Propel Bio Management, LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 604,664 shares valued at US$9.7M — a reduction of -266,796 shares quarter over quarter.. Notable position changes include a 945% increase in Q1 2025 (shares rose 7% over the following quarter), a 94% increase in Q3 2025 (shares fell 6% over the following quarter), a 123% increase in Q1 2026 (shares rose 36% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 17.00K $204.68K New
Q1 2025 177.60K $2.26M Add
Q2 2025 226.05K $3.07M Add
Q3 2025 438.51K $4.71M Add
Q4 2025 438.51K $4.43M Hold
Q1 2026 979.70K $9.16M Add
Q2 2026 871.46K $10.97M Reduce
Q3 2026 604.66K $9.66M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DCTH and 13F data

DCTH (DELCATH SYS INC) is a Health Care company. 45 other funds we track also report a position in DCTH — the largest reported positions include Rosalind Advisors, Inc. (US$41.6M), Simplify Asset Management Inc. (US$3.6M), Lane Generational LLC (US$2.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DCTH

All DCTH fund holders →

FAQ

How long has Propel Bio Management, LLC held DCTH?

Propel Bio Management, LLC has disclosed DCTH holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Propel Bio Management, LLC's current position in DCTH?

As of Q3 2026, Propel Bio Management, LLC holds 604.66K shares of DCTH (DELCATH SYS INC), valued at $9.66M, representing 5.12% of its reported portfolio and ranking #3.

Has Propel Bio Management, LLC been buying or selling DCTH?

In the latest 13F filing (Q3 2026), Propel Bio Management, LLC reduced its position in DCTH. The position peaked in Q2 2026 at 871.46K shares.

Which other funds hold DCTH?

Other major institutional holders of DCTH include Rosalind Advisors, Inc., Simplify Asset Management Inc., Lane Generational LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.